R&D Systems™ Rat IL-17E, Carrier-Free Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 8949IL025/CF
DescriptionThe Recombinant Rat IL-17E Protein is derived from HEK293. The Recombinant Rat IL-17E Protein has been validated for the following applications: Bioactivity.
|Human embryonic kidney cell, HEK293-derived Val17-Ala169|
|Observed M.W.: 19-25kDa, reducing conditions, Theoretical M.W.: 18kDa|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -70° C under sterile conditions after reconstitution.|
|IL17E, IL-17E, IL17Einterleukin-17E, IL25, IL-25, interleukin 17E, interleukin 25, Interleukin-17E, interleukin-25|
|>80%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining|
|Human embryonic kidney cell,HEK293-derived rat IL-17E/IL-25 protein Val17-Ala169|
|<0.10 EU per 1μg of the protein by the LAL method.|
|Measured by its ability to induce CXCL1/GRO alpha secretion in HT-29 human colon adenocarcinoma cells. The ED50 for this effect is typically 0.25-1.25ng/mL.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok